Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Jun 21, 2022 5:00pm
352 Views
Post# 34772355

RE:RE:RE:RE:RE:Dr. Arkady Mandel said

RE:RE:RE:RE:RE:Dr. Arkady Mandel saidCancerSlayer as you are aware I can barely get around in medical vernacular however you wrote 
The key to a durable response/cure for any solid tumor imo has to involve not only a robust cancer cell kill rate, but also a long-lasting protective immunity...for some, inducing the latter may require a form of cancer vaccine (i.e. serial boosters) or a combo treatment that engenders a more durable response.  Good luck.

As said a few patients had gone through other treatments & possibly other trials would there be a chance that because of the other treatments there could be a lasting affect to the immune system’s response to the positive or negative that should be noted by the lead investigators should that previous treatment replicate same response to patients moving from each specific treatment to TLD-1433? 


<< Previous
Bullboard Posts
Next >>